← All trials
NCT05664971
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 23, 2022
- Primary completion
- Sep 18, 2024
- Completion date
- Nov 17, 2024
- First posted
- Dec 26, 2022
- Last posted
- Dec 26, 2022
- Enrollment
- 240
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanghai Junshi Bioscience Co.,Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.